Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

Last updated:
2026-07-11
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

CANADIAN PROFILING AND TARGETED AGENT UTILIZATION TRIAL (CAPTUR) A PHASE II BASKET TRIAL

Intervention/treatment:
OLAPARIB/ NIVOLUMAB/ IPILIMUMAB/ CRIZOTINIB/ PALBOCICLIB/ SUNITINIB/ TEMSIROLIMUS/ ERLOTINIB/ TRASTUZUMAB/ PERTUZUMAB/ VEMURAFENIB/ COBIMETINIB/ VISMODEGIB/ TUCATINIB
Medical condition:
MULTIPLE MYELOMA
Protocol code:
PM.1
Control number:
208564
Status:
Recruiting
Approved:
September 20, 2017
Trial phase:
Phase 2
For more information:
ClinicalTrials.gov - NCT03297606
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Janet Dancey
Role
CONTACT
Phone:
613-533-6430
Sponsor
CANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITY

Locations

Alberta

Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2
RECRUITING
Name
Quincy Chu
Role
CONTACT
Phone:
780 432-8248

British Columbia

BCCA - Kelowna
Kelowna, British Columbia, V1Y 5L3
RECRUITING
Name
Sara Kristina Taylor
Role
CONTACT
Phone:
250 712-3996
BCCA - Vancouver
Vancouver, British Columbia, V5Z 4E6
RECRUITING
Name
Daniel John Renouf
Role
CONTACT
Phone:
604 877-6000
Extension 672357

Ontario

Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7
RECRUITING
Name
Francisco Vera-Badillo
Role
CONTACT
London Health Sciences Centre Research Inc.
London, Ontario, N6A 5W9
RECRUITING
Name
Stephen Welch
Role
CONTACT
Phone:
519 685-8640
Ottawa Hospital Research Institute
Ottawa, Ontario, K1H 8L6
RECRUITING
Name
John Hilton
Role
CONTACT
Phone:
613 737-7700
Extension 75086
University Health Network
Toronto, Ontario, M5G 2M9
RECRUITING
Name
Lillian Siu
Role
CONTACT
Phone:
416 946-2911

Quebec

The Jewish General Hospital
Montreal, Quebec, H3T 1E2
RECRUITING
Name
Cristiano Ferrario
Role
CONTACT
Phone:
514 398-8307

Saskatchewan

Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1
RECRUITING
Name
Kimberly Hagel
Role
CONTACT
Phone:
306 766-2691
Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4
RECRUITING
Name
Sunil K. Yadav
Role
CONTACT
Phone:
306 655-2710
Did you find what you were looking for?